Description
随访易(eVisit)，专注患者临床试验的平台。支持电子知情、患者原始病例上传、患者结局报告(ePRO)、随访管理及医患互动、各种消息提醒等功能。
Screenshots
随访易-专注患者临床试验管理 FAQ
-
Is 随访易-专注患者临床试验管理 free?
Yes, 随访易-专注患者临床试验管理 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 随访易-专注患者临床试验管理 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 随访易-专注患者临床试验管理 cost?
随访易-专注患者临床试验管理 is free.
-
What is 随访易-专注患者临床试验管理 revenue?
To get estimated revenue of 随访易-专注患者临床试验管理 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Canada yet.
Ratings History
随访易-专注患者临床试验管理 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
随访易-专注患者临床试验管理 Competitors
随访易-专注患者临床试验管理 Installs
Last 30 days
随访易-专注患者临床试验管理 Revenue
Last 30 days随访易-专注患者临床试验管理 Revenue and Downloads
Gain valuable insights into 随访易-专注患者临床试验管理 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Zhejiang Taimei Medical Technology Co
- Languages
- Chinese
- Recent release
- 3.2.5 (2 years ago )
- Released on
- Mar 31, 2019 (6 years ago )
- Also available in
- China, Hong Kong SAR China, Hungary, Poland, Chile, Argentina, Austria, Sweden, Switzerland, Indonesia, Kuwait, Kazakhstan, Lebanon, Colombia, Czechia, Germany, Denmark, Spain, Egypt, Saudi Arabia, Ireland, Philippines, Portugal, France, United Kingdom, Russia, Mexico, Malaysia, Nigeria, Netherlands, Estonia, Israel, Belarus, Romania, Taiwan, United Arab Emirates, Pakistan, Finland, India, Norway, New Zealand, South Africa, Brazil, Azerbaijan, Australia, Dominican Republic, Peru, Algeria, Ecuador, Singapore, Thailand, Türkiye, Ukraine, United States, Vietnam, Belgium, Canada, Italy, Japan, Greece, South Korea
- Last Updated
- 3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.